Radiopharm Theranostics Ltd (RADX) stock
RADXNasdaqPharmaceutical PreparationsFiscal year ends June 30Also trades as RDPTF
Số liệu tài chính tới năm tài chính 2026, năm kết thúc ngày Jun 30, 2026Last filing: 20-F on Sep 30, 2026Score 6/30
$0.77+0.01 (+1.00%)
Close on Nov 16, 2026Market cap $9.07MP/E –Yield –
Radiopharm Theranostics ebitda
EBITDA is earnings before interest, taxes, depreciation and amortization, a rough measure of cash profit from operations.
For fiscal 2026 it was -$54.08M.
Annual ebitda
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2026 | Jun 30, 2026 | -$54.08M | – |
| FY2025 | Jun 30, 2025 | -$35.58M | – |
| FY2024 | Jun 30, 2024 | -$44.08M | – |
| FY2023 | Jun 30, 2023 | -$31.19M | – |
See a number that looks wrong?